BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26083988)

  • 21. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
    Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
    Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in a cohort of patients with venous thromboembolism treated with vitamin K antagonists.
    Demelo-Rodríguez P; Postigo-Esteban A; García-Fernández-Bravo I; Agud M; Calpena S; Camacho M; Del Toro-Cervera J
    Thromb Res; 2016 Nov; 147():58-60. PubMed ID: 27676254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HIPOGAIA study: Monitoring of oral anticoagulation with vitamin K antagonists in the municipality of Gaia.
    Guedes M; Rego C
    Rev Port Cardiol; 2016 Sep; 35(9):459-65. PubMed ID: 27503590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea.
    Szymanski FM; Lip GY; Filipiak KJ; Platek AE; Karpinski G
    Int J Cardiol; 2016 Feb; 204():200-5. PubMed ID: 26670173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol.
    Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Marín F; Lip GYH
    Clin Ther; 2018 Jan; 40(1):114-122. PubMed ID: 29275065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
    Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation.
    Van Den Ham HA; Klungel OH; Leufkens HG; Van Staa TP
    J Thromb Haemost; 2013 Jan; 11(1):107-15. PubMed ID: 23088617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
    Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in patients with venous thromboembolism treated with vitamin K antagonists: Findings from the RIETE registry.
    Del-Toro-Cervera J; Demelo-Rodriguez P; Galeano-Valle F; Fidalgo Á; Sampériz Á; Muñoz-Torrero JFS; Lima J; Sigüenza P; Tufano A; Monreal M;
    Thromb Res; 2020 Oct; 194():178-182. PubMed ID: 32788113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
    Pokorney SD; Simon DN; Thomas L; Fonarow GC; Kowey PR; Chang P; Singer DE; Ansell J; Blanco RG; Gersh B; Mahaffey KW; Hylek EM; Go AS; Piccini JP; Peterson ED;
    Am Heart J; 2015 Jul; 170(1):141-8, 148.e1. PubMed ID: 26093875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The quality of oral anticoagulation in general practice in patients with atrial fibrillation.
    Mueller S; Pfannkuche M; Breithardt G; Bauersachs R; Maywald U; Kohlmann T; Wilke T
    Eur J Intern Med; 2014 Mar; 25(3):247-54. PubMed ID: 24477050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulation control in different ethnic groups receiving vitamin K antagonist therapy for stroke prevention in atrial fibrillation.
    Zulkifly H; Cheli P; Lutchman I; Bai Y; Lip GYH; Lane DA
    Thromb Res; 2020 Aug; 192():12-20. PubMed ID: 32416364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of co-morbidities and patient characteristics on international normalized ratio control over time in patients with nonvalvular atrial fibrillation.
    Nelson WW; Choi JC; Vanderpoel J; Damaraju CV; Wildgoose P; Fields LE; Schein JR
    Am J Cardiol; 2013 Aug; 112(4):509-12. PubMed ID: 23800552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INR variability in atrial fibrillation: a risk model for cerebrovascular events.
    Amouyel P; Mismetti P; Langkilde LK; Jasso-Mosqueda G; Nelander K; Lamarque H
    Eur J Intern Med; 2009 Jan; 20(1):63-9. PubMed ID: 19237095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT).
    Lip GY; Waldo AL; Ip J; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen M; Halperin JL;
    Am J Cardiol; 2016 Dec; 118(11):1680-1684. PubMed ID: 27665206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Affecting the Quality of Anticoagulation With Vitamin K Antagonists in Venous Thromboembolism Patients.
    Rivera-Caravaca JM; Viedma-Viedma I; Roldán V
    Biol Res Nurs; 2017 Mar; 19(2):198-205. PubMed ID: 27680769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of Vitamin K Antagonist Anticoagulation in Spain: Prevalence of Poor Control and Associated Factors.
    Anguita Sánchez M; Bertomeu Martínez V; Cequier Fillat Á;
    Rev Esp Cardiol (Engl Ed); 2015 Sep; 68(9):761-8. PubMed ID: 25814183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of anticoagulation with warfarin across Kuwait.
    Zubaid M; Saad H; Ridha M; Mohanan Nair KK; Rashed W; Alhamdan R; Alenezi F; Maghami M; Sadek A
    Hellenic J Cardiol; 2013; 54(2):102-6. PubMed ID: 23557609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists.
    Lobos-Bejarano JM; Castellanos Rodríguez A; Barrios V; Escobar C; Polo-García J; Del Castillo-Rodríguez JC; Vargas-Ortega D; Lopez-Pineda A; Prieto-Valiente L; Lip GYH;
    Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28722795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.